Nitric Oxide and Cardiac Muscarinic Control in Humans

Hypertension

Volumn 43, Issue 5, 2004, Pages 1023-1028

  Chowdhary, Saqib ^a   Marsh, Anna M ^a   Coote, John H ^a   Townend, Jonathan N ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Acetylcholine; Autonomic nervous system; Catecholamines; Heart rate; Myocardial contraction; Nitric oxide; Receptors

Indexed keywords

ACETYLCHOLINE; CATECHOLAMINE DERIVATIVE; CHOLINESTERASE INHIBITOR; EDROPHONIUM; MUSCARINIC RECEPTOR; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC STIMULATION; CHOLINERGIC SYSTEM; CHRONOTROPISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HEART; HEART CONTRACTION; HEART FAILURE; HEART PROTECTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN EXPERIMENT; INOTROPISM; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SINGLE BLIND PROCEDURE; VASOCONSTRICTION;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; BRADYCARDIA; CARDIOTONIC AGENTS; CHOLINESTERASE INHIBITORS; CROSS-OVER STUDIES; EDROPHONIUM; ENZYME INHIBITORS; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; ISOPROTERENOL; MALE; MUSCARINIC AGONISTS; NITRIC OXIDE; OMEGA-N-METHYLARGININE; PARASYMPATHETIC NERVOUS SYSTEM; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, MUSCARINIC; SINGLE-BLIND METHOD; SPECIES SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTOR AGENTS;

EID: 2342454577     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000126171.46645.f9     Document Type: Article

References (28)

1. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JMM, Fox KAA. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation. 1998;98:1510-1516.
2. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT, Jr, Camm AJ, Schwartz PJ. Baroreflex sensitivity and heart rate variability in the identification of patients at fisk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072-2077.
3. Cohn JN, Levine TB, Orivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
4. Vanoli E, De FGM, Stramba-Badiale M, Hull SS, Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68:1471-1481.
5. Levy MN, Zieske H. Autonomic control of cardiac pacemaker activity and atrioventricular transmission. J Appl Physiol. 1969;27:465-470.
6. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J. 2001;22:1136-1143.
7. Chowdhary S, Townend JN. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin Sci. 1999;97:5-17.
8. Armour JA, Smith FM, Losier AM, Ellenberger HH, Hopkins DA. Modulation of intrinsic cardiac neuronal activity by nitric oxide donors induces cardiodynamic changes. Am J Physiol. 1995;268:R403-R413.
9. Klimaschewski L, Kummer W, Mayer B, Couraud JY, Preissler U, Philippin B, Heym C. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ Res. 1992;71:1533-1537.
10. Han X, Kobzik L, Severson D, Shimoni Y. Characteristics of nitric oxide-mediated cholinergic modulation of calcium current in rabbit sino-atrial node. J Physiol. 1998;509:741-754.
11. Conlon K, Kidd C. Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. J Auton Nerv Sys. 1999;75:136-146.
12. Herring N, Paterson DJ. Nitric oxide-cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea-pig in vitro. J Physiol. 2001;535:507-518.
13. Elvan A, Rubart M, Zipes DP. NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am J Physiol. 1997;272:H263-H271.
14. Choate JK, Danson EJ, Morris IF, Paterson DJ. Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice. Am J Physiol. 2001;281:H2310-H2317.
15. Sears CE, Choate JK, Paterson DJ. Inhibition of nitric oxide synthase slows heart rate recovery from cholinergic activation. J Appl Physiol. 1998;84:1596-1603.
16. Balligand JL. Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res. 1999;43:607-620.
17. Chowdhary S, Vaile JC, Fletcher J, Ross HF, Coote JH, Townend JN. Nitric oxide and cardiac autonomic control in humans. Hypertension. 2000;36:264-269.
18. Chowdhary S, Ng GA, Nuttall SL, Coote JH, Ross HF, Townend JN. Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci. 2002;102:397-402.
19. Chowdhary S, Nuttall SL, Coote JH, Townend JN. L-arginine augments cardiac vagal control in healthy human subjects. Hypertension. 2002;39:51-56.
20. Palomo AR, Quinones MA, Waggoner AD, Kumpuris AG, Miller RR. Echo-phonocardiographic determination of left atrial and left ventricular filling pressures with and without mitral stenosis. Circulation. 1980;61:1043-1047.
21. Higgins CB, Vatner SF, Braunwald E. Parasympathetic control of the heart. Pharmacol Rev. 1973;25:119-155.
22. Landzberg J, Parker J, Gauthier D, Colucci W. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation. 1994;89:164-168.
23. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
24. Mohan RM, Heaton DA, Danson EJ, Krishnan SP, Cai S, Channon KM, Paterson DJ. Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function. Circ Res. 2002;91:1089-1091.
25. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA, Michel T. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem. 1998;273:30249-30254.
26. Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation. 1998;97:161-166.
27. Node K, Kitakaze M, Yoshihara F, Sasaki T, Kuzuya T, Hori M. Increased cardiac levels of nitric oxide in patients with chronic heart failure. Am J Cardiol. 2000;86:474-477.
28. Katona P, McLean M, Dighton D, Guz A. Sympathetic and parasympathetic cardiac control in athletes and non-athletes at rest. J Appl Physiol. 1982;52:1652-1657.